D. Warnock

发表

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection.

D. Denning, K. Oakley, S. Radford, 1997, The Journal of antimicrobial chemotherapy.

Itraconazole resistance in Aspergillus fumigatus

S. Kelly, D. Denning, M. Anderson, 1997, Antimicrobial agents and chemotherapy.

Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.

E. Johnson, D. Warnock, K. Davey, 1998, The Journal of antimicrobial chemotherapy.

Quantitation of Candida albicans Ergosterol Content Improves the Correlation between In Vitro Antifungal Susceptibility Test Results and In Vivo Outcome after Fluconazole Treatment in a Murine Model of Invasive Candidiasis

B. Arthington-Skaggs, D. Warnock, C. J. Morrison, 2000, Antimicrobial Agents and Chemotherapy.

Interlaboratory Comparison of Results of Susceptibility Testing with Caspofungin against Candida and Aspergillus Species

J. Perfect, M. Ghannoum, W. Schell, 2004, Journal of Clinical Microbiology.

Drug resistance genes and trailing growth in Candida albicans isolates.

Mi-Kyung Lee, B. Arthington-Skaggs, D. Warnock, 2004, The Journal of antimicrobial chemotherapy.

Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome

S. Fridkin, L. Harrison, B. Plikaytis, 2006, Antimicrobial Agents and Chemotherapy.

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

M. Ghannoum, J. Rex, T. Walsh, 2006, Journal of Clinical Microbiology.

Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients.

A. Prentice, D. Warnock, M. J. Phillips, 1994, The Journal of antimicrobial chemotherapy.

Candida dubliniensis fungemia: the first four cases in North America.

L. Harrison, M. Brandt, R. Hajjeh, 2000, Emerging infectious diseases.

Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers

Benjamin J Park, B. Arthington-Skaggs, A. Colombo, 2006, Journal of Clinical Microbiology.

Serodiagnosis: Antibody and Antigen Detection

D. Warnock, C. J. Morrison, 2007 .

Serological and Molecular Diagnosis of Fungal Infections

D. Warnock, C. J. Morrison, M. Lindsley, 2006 .

Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature.

G. Lyon, J. Guarner, T. Colby, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunological aspects of candidosis in AIDS patients.

D. Warnock, 1990 .

Resolution of Discrepant Results for Candida Species Identification by Using DNA Probes

M. Brandt, D. Warnock, C. J. Morrison, 2004, Journal of Clinical Microbiology.

Comparison of In Vitro Antifungal Activities of Free and Liposome-Encapsulated Nystatin with Those of Four Amphotericin B Formulations

J. Ojwang, Elizabeth M. Johnson, D. Warnock, 1998, Antimicrobial Agents and Chemotherapy.

Rapid Quantification of Drug Resistance Gene Expression in Candida albicans by Reverse Transcriptase LightCycler PCR and Fluorescent Probe Hybridization

B. Arthington-Skaggs, D. Warnock, J. P. Frade, 2004, Journal of Clinical Microbiology.

Chaetomium pneumonia in patient with acute myeloid leukaemia.

C. K. Campbell, H. Prentice, C. Kibbler, 1996, Journal of clinical pathology.

Pharmacokinetic study of the interaction between rifampicin and ketoconazole.

D. Warnock, R. Shaw, C. Rowland-Hill, 1988, The Journal of antimicrobial chemotherapy.

Aspergillus antigen testing in bone marrow transplant recipients

Elizabeth M. Johnson, E. Johnson, D. Warnock, 2000, Journal of clinical pathology.

Itraconazole and fluconazole: new drugs for deep fungal infection.

D. Warnock, 1989, The Journal of antimicrobial chemotherapy.

Epidemiology of Systemic Fungal Diseases: An Overview

M. Brandt, Benjamin J Park, T. Chiller, 2011 .

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

M. Cuenca‐Estrella, M. Giménez, J. Rodríguez-Tudela, 2005, The Journal of antimicrobial chemotherapy.

Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003

S. Fridkin, Benjamin J Park, M. Cuenca‐Estrella, 2005, Journal of Clinical Microbiology.

Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man.

E. Johnson, D. Warnock, M. Richardson, 1983, The Journal of antimicrobial chemotherapy.

Name Changes for Fungi of Medical Importance, 2016–2017

D. Warnock, 2018, Journal of Clinical Microbiology.

Name Changes for Fungi of Medical Importance, 2012 to 2015

D. Warnock, 2016, Journal of Clinical Microbiology.

In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.

E. Johnson, D. Warnock, A. Székely, 1998, The Journal of antimicrobial chemotherapy.

Fungal diseases: an evolving public health challenge.

D. Warnock, 2006, Medical mycology.

A Large Histoplasmosis Outbreak Among High School Students in Indiana, 2001

J. W. Fleming, M. Brandt, R. Hajjeh, 2004, The Pediatric infectious disease journal.

Azole Drug Resistance as a Cause of Clinical Relapse in AIDS Patients with Cryptococcal Meningitis

C. Parry, D. Warnock, E. Johnson, 1995, International journal of STD & AIDS.

Epidemiology: surveillance of fungal infections.

D. Marriott, R. Barton, W. Meyer, 2000, Medical mycology.

An epidemic of coccidioidomycosis in Arizona associated with climatic changes, 1998-2001.

J. Galgiani, A. Comrie, K. Sigel, 2005, The Journal of infectious diseases.

Typing of Candida albicans.

D. Warnock, 1984, The Journal of hospital infection.

Epidemiological investigation of patients with vulvovaginal candidosis. Application of a resistogram method for strain differentiation of Candida albicans.

D. Warnock, C. Speller, J. D. Milne, 1979, The British journal of venereal diseases.

Resistogram method for differentiation of strains of Candida albicans.

J. K. Day, D. Warnock, D. Speller, 1979, The Journal of applied bacteriology.

Molecular Epidemiological Study ofAspergillus fumigatus in a Bone Marrow Transplantation Unit by PCR Amplification of Ribosomal Intergenic Spacer Sequences

J. Cornish, M. Millar, Elizabeth M. Johnson, 1998, Journal of Clinical Microbiology.

Antibodies to Candida albicans in human cervicovaginal secretions.

D. Warnock, J. D. Milne, 1977, The British journal of venereal diseases.

Coccidioides species as potential agents of bioterrorism.

D. Warnock, 2007, Future microbiology.

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies

A. Prentice, D. Warnock, G. Morgenstern, 1999 .

Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy.

R. Hay, D. Denning, J. Cohen, 1997, The Journal of antimicrobial chemotherapy.

FOCUS Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

M. Ghannoum, J. Rex, T. Walsh, 2001 .

Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999.

G. Lyon, R. Hajjeh, M. McNeil, 2004, The American journal of tropical medicine and hygiene.

Coccidioidomycosis among Workers at an Archeological Site, Northeastern Utah

D. Dennis, L. Petersen, R. Hajjeh, 2004, Emerging infectious diseases.

Travel-Associated Fungal Infections

R. Hajjeh, D. Warnock, 2004 .

Fungal infections among returning travelers.

M. Cetron, R. Hajjeh, D. Warnock, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Outbreak of invasive aspergillosis among renal transplant recipients.

Joseph C. Carpenter, L. Mascola, M. Brandt, 2003, Transplantation.

Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru.

G. Lyon, K. Shutt, M. Brandt, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical manifestations and management of aspergillosis in the compromised patient.

D. Warnock, M. Richardson, J. Cohen, 1990 .

Antifungal drug susceptibility testing and resistance in Aspergillus.

B. Arthington-Skaggs, D. Warnock, Ren-Kai Li, 1999, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Comparison of multilocus sequence typing and Ca3 fingerprinting for molecular subtyping epidemiologically-related clinical isolates of Candida albicans.

A. Chowdhary, M. Brandt, B. Arthington-Skaggs, 2006, Medical mycology.

Manual of Clinical Microbiology, 11th Edition

James H. Jorgensen, David W. Warnock, Karen C. Carroll, 2015 .

Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.

E. Johnson, D. Warnock, D. White, 1993, Genitourinary medicine.

Rapid Acquisition of Stable Azole Resistance by Candida glabrata Isolates Obtained before the Clinical Introduction of Fluconazole

B. Arthington-Skaggs, D. Warnock, C. J. Morrison, 2005, Antimicrobial Agents and Chemotherapy.

In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.

J. Vazquez, B. Arthington-Skaggs, A. Espinel-Ingroff, 2000, Medical mycology.

Itraconazole more bioavailable in solution.

A. Prentice, D. Warnock, 1996, Blood.

Fatal Candida tropicalis fungaemia in a leukaemic patient receiving fluconazole prophylaxis.

A. Wardley, B. Oppenheim, E. Johnson, 1996, The Journal of infection.

Azole drug resistance in Candida species.

D. Warnock, 1992, Journal of medical microbiology.

New developments in the diagnosis of opportunistic fungal infection

D. Warnock, V. Hopwood, David W. Warnock, 1986, European Journal of Clinical Microbiology.

Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia.

A. Prentice, D. Warnock, S. Johnson, 1995, The Journal of antimicrobial chemotherapy.

In-vitro resistance to imidazole antifungals in Candida albicans.

E. Johnson, D. Warnock, M. Richardson, 1984, The Journal of antimicrobial chemotherapy.

Evolving strategies in the management of aspergillosis

S. Magill, T. Chiller, D. Warnock, 2008 .

Rhizopus microsporus in wooden tongue depressors: a major threat or minor inconvenience?

C. K. Campbell, E. Johnson, D. Warnock, 1998, The Journal of hospital infection.

Fluconazole resistance in Candida glabrata

P. Troke, E. Johnson, D. Warnock, 1993, Antimicrobial Agents and Chemotherapy.

Amphotericin B: an introduction.

D. Warnock, 1991, The Journal of antimicrobial chemotherapy.

Clinical Pharmacokinetics of Systemic Antifungal Drugs

D. Warnock, T. Daneshmend, T. Daneshmend, 1983, Clinical pharmacokinetics.

Assay of Fungal Mycelium in Grains of Barley, including the Use of the Fluorescent Antibody Technique for Individual Fungal Species

D. Warnock, 1971 .

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group.

H. Prentice, A. Prentice, D. Warnock, 1999, British journal of haematology.

Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia.

A. Prentice, D. Warnock, J. Copplestone, 1991, The Journal of antimicrobial chemotherapy.

Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993.

A. MacGowan, D. Reeves, D. Warnock, 1995, The Journal of antimicrobial chemotherapy.

Origin and development of fungal mycelium in grains of barley before harvest

D. Warnock, 1973 .

Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program

Lee H. Harrison, David W. Warnock, G. Lyon, 2004, Journal of Clinical Microbiology.

Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies.

D. Warnock, M. Richardson, J. Stubbins, 1982, Journal of Clinical Pathology.

Further evaluation of factors affecting a rapid ELISA procedure for detection of IgG antibodies to Candida albicans

D. Warnock, M. Richardson, Susan M. Smith, 1983, Mycopathologia.

Use of Aspergillus fumigatus Culture Filtrate Fractions in ELISA for the Serological Diagnosis of Allergic Aspergillosis

Z. U. Khan, D. Warnock, D. Crutcher, 1984, Mykosen.

Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the diagnosis of Aspergillus fumigatus intranasal infection of the dog.

Z. U. Khan, J. Lane, D. Warnock, 1984, Sabouraudia.

Rapid enzyme‐linked immunosorbent assay (ELISA) for the detection of IgG antibodies against

D. Warnock, M. Richardson, Z. Khan, 1984, Clinical allergy.

Antibody to Aspergillus fumigatus antigens in normal sera: influence on positive-negative discrimination in ELISA.

D. Warnock, M. Richardson, P. A. Llewellyn, 1984, Journal of immunoassay.

Antigen and antibody attachment in ELISA for Aspergillus fumigatus IgG antibodies.

D. Warnock, M. Richardson, 1984, Journal of immunological methods.

Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis.

D. Warnock, M. Richardson, A. Turner, 1983, Journal of immunological methods.

Enzyme-linked immunosorbent assay and its application to the serological diagnosis of fungal infection.

D. Warnock, M. Richardson, 1983, Sabouraudia.

Further evaluation of indirect immunofluorescence methods for detection of antibodies against Aspergillus fumigatus.

D. Warnock, E. M. Hann, 1981, Sabouraudia.

Detection of Aspergillus fumigatus precipitins: a comparison of counter immunoelectrophoresis and double diffusion.

D. Warnock, 1977, Journal of clinical pathology.

Indirect immunofluorescence test for the detection of Aspergillus fumigatus antibodies

D. Warnock, 1974, Journal of clinical pathology.

Comparative Evaluation of PASCO and National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Yeasts

B. Arthington-Skaggs, D. Warnock, C. J. Morrison, 2000, Journal of Clinical Microbiology.

Assessment of Ribosomal Large-Subunit D1-D2, Internal Transcribed Spacer 1, and Internal Transcribed Spacer 2 Regions as Targets for Molecular Identification of Medically Important Aspergillus Species

T. Lott, D. Warnock, C. J. Morrison, 2005, Journal of Clinical Microbiology.

FLUCONAZOLE RESISTANCE IN CANDIDA GLABRATA

E. Johnson, D. Warnock, J. Burke, 1988, The Lancet.

Comparison of the API Candida System with the AUXACOLOR System for Identification of Common Yeast Pathogens

C. K. Campbell, D. Warnock, A. Székely, 1999, Journal of Clinical Microbiology.

Evaluation of the AUXACOLOR system, a new method of clinical yeast identification.

C. K. Campbell, D. Warnock, K. Davey, 1995, Journal of clinical pathology.

Multicenter evaluation of Microring YT, a new method of yeast identification

D. Warnock, M. Richardson, E. Evans, 1990, Journal of clinical microbiology.

Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

M. Ghannoum, J. Rex, T. Walsh, 2001, Clinical Microbiology Reviews.

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

B. Plikaytis, R. Hajjeh, M. McNeil, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.

B. Arthington-Skaggs, D. Warnock, C. J. Morrison, 2000, Journal of clinical microbiology.

Toxic gas generation from plastic mattresses and sudden infant death syndrome

C. K. Campbell, E. Johnson, D. Warnock, 1995, The Lancet.

In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens

Elizabeth M. Johnson, D. Warnock, A. Székely, 1999, Antimicrobial Agents and Chemotherapy.

Standardized susceptibility testing of fluconazole: an international collaborative study

T. Walsh, M. Rinaldi, A. Espinel-Ingroff, 1992, Antimicrobial Agents and Chemotherapy.

Comparison of E-Test and Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Molds

Elizabeth M. Johnson, D. Warnock, A. Székely, 1999, Journal of Clinical Microbiology.

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program.

K. Wannemuehler, S. Fridkin, D. Kontoyiannis, 2005, Medical mycology.

CHAPTER 32 – Antifungal agents

D. Warnock, 2010 .

Laboratory Aspects of Medical Mycology

S. Lockhart, M. Brandt, D. Warnock, 2011 .

Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation

R. E. Warren, T. R. Rogers, C. C. Kibbler, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Fortnightly Review: Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology)

D. Denning, C. Kibbler, R. Warren, 1995, BMJ.

14 – Superficial Fungal Infections

T. Chiller, D. Warnock, 2017 .

Intra- and Interlaboratory Study of a Method for Testing the Antifungal Susceptibilities of Dermatophytes

M. Ghannoum, M. Pfaller, M. Rinaldi, 2004, Journal of Clinical Microbiology.

Nail infection caused by Onychocola canadensis: report of the first four British cases.

C. K. Campbell, E. Johnson, D. Warnock, 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Bioassays for itraconazole blood levels: an interlaboratory collaborative study.

D. Stevens, F. Odds, M. Rinaldi, 1999, The Journal of antimicrobial chemotherapy.

Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole.

D. Warnock, J. Burke, A. Turner, 1988, The Journal of antimicrobial chemotherapy.

Antifungal drug susceptibility testing.

D. Warnock, 1997, Current topics in medical mycology.

MODIFIED RESPONSE TO KETOCONAZOLE OF CANDIDA ALBICANS FROM A TREATMENT FAILURE

E. Johnson, D. Warnock, M. Richardson, 1983, The Lancet.

Clinical Pharmacokinetics of Ketoconazole

David W. Warnock, D. Warnock, Tawfique K. Daneshmend, 1988, Clinical pharmacokinetics.

Laboratory methods for flucytosine (5-fluorocytosine)

R. Hay, F. Odds, D. Warnock, 1984 .

Fungal infection in the compromised patient.

D. Warnock, M. Richardson, 1982 .

Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans.

E. Johnson, D. Warnock, M. Richardson, 1983, The Journal of antimicrobial chemotherapy.

Influence of food on the pharmacokinetics of ketoconazole

E. Johnson, D. Warnock, M. Richardson, 1984, Antimicrobial Agents and Chemotherapy.

Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis.

D. Warnock, J. D. Milne, 1979, The British journal of venereal diseases.

Effect of Ketoconazole on the Initial Stages of Germ Tube Formation by Strains of Candida albicans

E. Johnson, D. Warnock, M. L. Barnard, 1982, Mykosen.

In-vitro effects of liposome-encapsulated amphotericin B (AmBisome) and amphotericin B-deoxycholate (Fungizone) on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.

P. J. Elliot, E. Johnson, D. Warnock, 1992, The Journal of antimicrobial chemotherapy.

Effect of antimicrobial and antineoplastic drugs alone and in combination on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.

D. Warnock, C. Pallister, 1989, The Journal of antimicrobial chemotherapy.

In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils.

E. Johnson, D. Warnock, M. Richardson, 1986, The Journal of antimicrobial chemotherapy.

Determination of miconazole in human saliva using high-performance liquid chromatography.

D. Warnock, A. Turner, 1982, Journal of chromatography.

Pharmacokinetics of ketoconazole in normal subjects.

D. Warnock, T. Daneshmend, C. Roberts, 1981, The Journal of antimicrobial chemotherapy.

Molecular biological characterization of an azole-resistant Candida glabrata isolate

C. van Broeckhoven, V. Timmerman, F. Odds, 1997, Antimicrobial agents and chemotherapy.

Prevalence and persistence of different strains of Candida albicans in treatment of denture stomatitis.

D. Warnock, M. C. McCreight, A. Watkinson, 1985, The Journal of prosthetic dentistry.

Prevalence of different strains of Candida albicans in patients with denture-induced stomatitis.

D. Warnock, M. C. McCreight, A. Watkinson, 1984, Sabouraudia.

Serum itraconazole concentrations and clinical responses in Candida-associated denture stomatitis patients treated with itraconazole solution and itraconazole capsules.

J. Bagg, D. Warnock, L. Cross, 2000, The Journal of antimicrobial chemotherapy.

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis.

C Scully, C. Scully, Elizabeth M. Johnson, 1995, The Journal of antimicrobial chemotherapy.

Disseminated infection due to Cylindrocarpon lichenicola in a patient with acute myeloid leukaemia.

A. Mehta, C. Kibbler, E. Johnson, 1997, The Journal of infection.

Use of the Pastorex aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis.

E. Johnson, D. Warnock, E. Evans, 1995, Journal of clinical pathology.

Use of a Repetitive DNA Probe To Type Clinical and Environmental Isolates of Aspergillus flavus from a Cluster of Cutaneous Infections in a Neonatal Intensive Care Unit

M. McNeil, D. Warnock, E. Reiss, 2000, Journal of Clinical Microbiology.

KETOCONAZOLE AND FUNGAL CAPD PERITONITIS

D. Warnock, J. Chapman, 1983, The Lancet.

Mechanisms and clinical impact of antifungal drug resistance.

S. Sen Gupta, D. Kerridge, L. Improvisi, 1994, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Clinical manifestations and management of cryptococcosis in the compromised patient.

R. Hay, D. Warnock, M. Richardson, 1990 .

Itraconazole pulse: an overview of current use.

D. Warnock, 1998, Hospital Medicine.

Introduction to the management of fungal infection in the compromised patient.

D. Warnock, M. Richardson, 1990 .

Clinical manifestations and management of mucormycosis in the compromised patient.

B. Wong, D. Armstrong, D. Warnock, 1990 .

Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection.

D. Denning, K. Oakley, P. Warn, 2000, The Journal of antimicrobial chemotherapy.

Acremonium infection in a neutropenic patient.

N. M. Brown, D. Warnock, S. Chown, 1992, The Journal of infection.

An outbreak of aspergillosis in a general ITU.

H Humphreys, H. Humphreys, S. Willatts, 1991, The Journal of hospital infection.

Treatment failure in a case of fungal keratitis caused by Pseudallescheria boydii.

P. Bloom, D. Easty, D. Warnock, 1992, The British journal of ophthalmology.

Serological diagnosis of infection of the urinary tract by yeasts.

P. Mackie, J. Morris, D. Warnock, 1976, Journal of clinical pathology.

Histoplasma, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses.

M. Brandt, D. Warnock, B. Gómez, 2011 .

Fungal complications of transplantation: diagnosis, treatment and prevention.

D. Warnock, 1995, The Journal of antimicrobial chemotherapy.

Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.

T. Rogers, E. Johnson, D. Warnock, 1998, The Journal of antimicrobial chemotherapy.

Coccidioidomycosis in India: report of a second imported case.

A. Padhye, D. Warnock, S. Verghese, 2002, Medical mycology.

In Vitro Activities of Voriconazole, Itraconazole, and Amphotericin B against Blastomyces dermatitidis,Coccidioides immitis, and Histoplasma capsulatum

M. Mcginnis, D. Warnock, M. Ciblak, 2000, Antimicrobial Agents and Chemotherapy.

VAGINAL CANDIDIASIS AND THE ROLE OF THE DIGESTIVE TRACT AS A SOURCE OF INFECTION

D. Warnock, A. Hilton, 1975, British journal of obstetrics and gynaecology.

Candidosis of the genital tract in non-pregnant women.

P. Gough, E. Johnson, D. Warnock, 1985, European journal of obstetrics, gynecology, and reproductive biology.

Treatment of vaginal candidiasis with miconazole.

A. J. Scott, D. Warnock, J. D. Milne, 1977, Current medical research and opinion.

Intermittent local prophylaxis against recurrent vaginal candidosis.

J. Meaden, D. Warnock, E. Evans, 1988, Genitourinary medicine.

High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs.

D. Warnock, M. Richardson, A. Turner, 1982, The Journal of antimicrobial chemotherapy.

Ketoconazole pharmacokinetics during chronic dosing in adults with haematological malignancy

D. Warnock, M. Richardson, T. Daneshmend, 1986, European Journal of Clinical Microbiology.

Detection ofAspergillus fumigatus precipitins: a comparison ofcounter immunoelectrophoresis anddouble diffusion

D. Warnock, 1977 .

Immunoglobulin classes of antibodies to Aspergillus fumigatus in patients with pulmonary aspergillosis.

D. Warnock, G. F. Eldred, 1975, Sabouraudia.

Trends in the epidemiology of invasive fungal infections.

D. Warnock, 2007, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

Clinical manifestations and management of hyalohyphomycosis, phaeohyphomycosis and other uncommon forms of fungal infection in the compromised patient.

E. Johnson, D. Warnock, M. Richardson, 1990 .

Sporothrix schenckii sensitivity to voriconazole, itraconazole and amphotericin B.

M. Mcginnis, D. Warnock, L. Pasarell, 2001, Medical mycology.

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens

S. Radford, E. Johnson, D. Warnock, 1997, Antimicrobial agents and chemotherapy.

IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis.

P. Gough, D. Warnock, M. Richardson, 1984, Sabouraudia.

Influence of formulation on ketoconazole pharmacokinetics in man: comparison of standard tablet versus capsule containing citric acid.

E. Johnson, D. Warnock, T. Daneshmend, 1986, The Journal of antimicrobial chemotherapy.

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998

D. Rimland, A. Reingold, M. Brandt, 2001, Antimicrobial Agents and Chemotherapy.

Comparative Evaluation of NCCLS M27-A and EUCAST Broth Microdilution Procedures for Antifungal Susceptibility Testing of Candida Species

E. Mellado, M. Cuenca‐Estrella, B. Arthington-Skaggs, 2002, Antimicrobial Agents and Chemotherapy.

In-vitro susceptibility of Cryptococcus neoformans isolates to fluconazole and itraconazole.

E. Johnson, D. Warnock, K. Davey, 1998, The Journal of antimicrobial chemotherapy.

Serological diagnosis ofinfection oftheurinary tract byyeasts

P. Mackie, J. Morris, D. Warnock, 1976 .

The diagnosis and treatment of a case of nasal aspergillosis in a cat

J. Lane, D. Warnock, S. Goodall, 1984 .

High performance liquid chromatographic determination of 5-fluorocytosine in human serum.

D. Warnock, A. Turner, 1981, The Journal of antimicrobial chemotherapy.

VAGINAL CANDIDIASIS AND THE ROLE OF THE DIGESTIVE TRACT AS A SOURCE OF INFECTION

D. Warnock, A. Hilton, 1975, British journal of obstetrics and gynaecology.

Immunoglobulin classes of human serum antibodies in vaginal candidiasis

D. Warnock, A. Fielding, J. D. Milne, 1978, Mycopathologia.

Prevalence of oral colonization with Candida albicans and anti-C. albicans IgA in the saliva of normal children and children with acute lymphoblastic leukaemia

T. Gentle, O. Eden, D. Warnock, 1984, Mycopathologia.

Observations on the use of the double diffusion test in the diagnosis of vaginal candidiasis.

D. Warnock, G. Jones, 1977, Journal of clinical pathology.

Rapid enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies to Candida albicans

D. Warnock, M. Richardson, J. Stubbins, 2004, Mycopathologia.

Clinical manifestations and management of histoplasmosis in the compromised patient.

G. Sarosi, D. Warnock, M. Richardson, 1990 .

Clinical manifestations and management of coccidioidomycosis in the compromised patient.

D. Stevens, D. Warnock, M. Richardson, 1990 .

A large outbreak of histoplasmosis among American travelers associated with a hotel in Acapulco, Mexico, spring 2001.

Joseph C. Carpenter, D. Feikin, M. Brandt, 2003, The American journal of tropical medicine and hygiene.

High performance liquid chromatographic determination of ketoconazole in human serum.

D. Warnock, A. Turner, C. Turner, 1986, The Journal of antimicrobial chemotherapy.

Candida parapsilosis Characterization in an Outbreak Setting

M. Ghannoum, D. Soll, P. Mukherjee, 2004, Emerging infectious diseases.

Resistogram typing of Candida albicans isolates from oral and cutaneous sites in irradiated patients.

M. Martín, D. Warnock, M. C. McCreight, 1985, Sabouraudia.

A case of fungal contact lens contaminationby Alternaria alternata: the first British case report

P. Bloom, D. Warnock, A. Laidlaw, 1991 .

Observations on the useofthedouble diffusion test inthediagnosis ofvaginal candidiasis

D. Warnock, Bristol RoyalInfirmary, 1977 .

Identification of Pathogenic Fungi

C. K. Campbell, Elizabeth M. Johnson, D. Warnock, 1996 .

Epidemiology and prevention of invasive aspergillosis

R. Hajjeh, D. Warnock, B. Lasker, 2001, Current infectious disease reports.

Fungal infections in neutropenia: current problems and chemotherapeutic control.

D. Warnock, D W Warnock, 1998, The Journal of antimicrobial chemotherapy.

Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

D. Rimland, R. Kuykendall, M. McNeil, 2001, Medical mycology.

Persistence of Oropharyngeal Candida albicans Strains with Reduced Susceptibilities to Fluconazole among Human Immunodeficiency Virus-Seropositive Children and Adults in a Long-Term Care Facility

M. McNeil, D. Warnock, E. Reiss, 2003, Journal of Clinical Microbiology.

Report of the First Human Case of Lobomycosis in the United States

A. Padhye, D. Warnock, R. Burns, 2000, Journal of Clinical Microbiology.

Comparison of a new chromogenic agar with the germ tube method for presumptive identification ofCandida albicans

C. K. Campbell, D. Warnock, K. Davey, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Azole resistance in Candida albicans.

J. V. van Cutsem, E. Johnson, D. Warnock, 1986, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

Mycological techniques.

C. K. Campbell, D. Warnock, K. Davey, 1996, Journal of clinical pathology.

Identification of Pathogenic Fungi: Campbell/Identification of Pathogenic Fungi

C. K. Campbell, Elizabeth M. Johnson, D. Warnock, 2013 .

Taxonomy and classification of fungi.

M. Brandt, D. Warnock, 2011 .

Use of immunofluorescence to detect mycelium of Alternaria, Aspergillus and Penicillium in barley grains

D. Warnock, 1973 .

Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species.

E. Johnson, D. Warnock, K. Davey, 1995, The Journal of antimicrobial chemotherapy.

Candidemia in Neonatal Intensive Care Units: Barcelona, Spain

Benjamin J Park, M. Cuenca‐Estrella, A. Gené, 2006, The Pediatric infectious disease journal.

Clinical manifestations and management of superficial fungal infection in the compromised patient.

R. Hay, D. Warnock, M. Richardson, 1990 .

Fungal Infection in the Compromised Host

D. Warnock, M. Richardson, D. Howard, 1992 .

Clinical manifestations and management of candidosis in the compromised patient.

D. Warnock, B. Dupont, M. Richardson, 1990 .

Comparative Evaluation of FUNGITEST and Broth Microdilution Methods for Antifungal Drug Susceptibility Testing of Candida Species and Cryptococcus neoformans

Elizabeth M. Johnson, D. Warnock, A. Székely, 1998, Journal of Clinical Microbiology.

Moulds with Aleuriospores: I. The Dermatophytes

C. K. Campbell, Elizabeth M. Johnson, D. Warnock, 2013 .

Aspergillus antigen latex test for diagnosis of invasive aspergillosis

E. Johnson, D. Warnock, J. Cornish, 1991, The Lancet.

Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.

E. Johnson, D. Warnock, J. Burke, 1989, The Journal of antimicrobial chemotherapy.

Rapid serological diagnosis of Aspergillus fumigatus infection of the frontal sinuses and nasal chambers of the dog.

J. Lane, D. Warnock, M. Richardson, 1982, Research in veterinary science.

The diagnosis of Aspergillus fumigatus infection of the nasal chambers of the dog with particular reference to the value of the double diffusion test.

J. Lane, D. Warnock, 1977, The Journal of small animal practice.

Counterpoint: invasive aspergillosis and the environment--rethinking our approach to prevention.

R. Hajjeh, D. Warnock, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fungal infection in the compromised patient. 2nd edition.

D. Warnock, M. Richardson, 1991 .

In vitro phagocytosis ofCandida albicans by human polymorphonuclear phagocyte monolayers pretreated with anti-pseudomonal antibiotics

P. Hawkey, D. Warnock, M. Richardson, 1983, European Journal of Clinical Microbiology.

Another case report of rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery.

D. Warnock, C. Burns-Cox, K. K. Lim, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Penicillium marneffei infection

Richardson, D. Warnock, 1997 .

Location and extent of fungal mycelium in grains of barley

D. Warnock, T. Preece, 1971 .

Stability of Allelic Frequencies and Distributions of Candida albicans Microsatellite Loci from U.S. Population-Based Surveillance Isolates

L. Harrison, M. Brandt, R. Hajjeh, 2003, Journal of Clinical Microbiology.

Evaluation of a new slide latex agglutination test for diagnosis of vaginal candidosis

D. Warnock, T. Crowley, C. Horrocks, 1987, European Journal of Clinical Microbiology.

Vaginal candidosis: relation between yeast counts and symptoms and clinical signs in non-pregnant women.

D. Warnock, T. Crowley, C. Horrocks, 1988, Genitourinary medicine.

Treatment of hepatic candidosis with liposomal amphotericin B in patient with acute leukaemia

D. Warnock, J. Hudson, G. Scott, 1991, The Lancet.

Azole drug resistance in yeasts.

E. Johnson, D. Warnock, 1995, The Journal of antimicrobial chemotherapy.

Effect of methotrexate on the germination and growth of Aspergillus fumigatus and Aspergillus flavus strains.

D. Warnock, D. Oliver, M. M. Cheung, 1992, The Journal of antimicrobial chemotherapy.

Liposomal amphotericin B and continuous venous-venous haemofiltration.

H. Humphreys, D. Warnock, D. Oliver, 1994, The Journal of antimicrobial chemotherapy.

Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits.

D. Rimland, R. Kuykendall, M. McNeil, 2001, Medical mycology.

Prophylactic Use of Clotrimazole in Recurrent Vaginal Candidosis

J. Meaden, D. Warnock, E. Evans, 1988, Annals of the New York Academy of Sciences.